Pharmaceutical industry: 600 million for Penzberg – Roche is sticking to its investment

Unlike Eli Lilly and Boehringer, Roche is continuing to invest in its diagnostics center as planned. The pharmaceutical company still calls the federal government's austerity law a serious threat.